XL184

cabozantinib · Exelixis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XL184, covering 2014-09-09 to 2014-09-09. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer [Phase 3]